Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Tekmira acquires license to RNAi technology

Nov. 30, 2012

Bayer and Leiden University to coordinate drug discovery consortium

Nov. 30, 2012

Evotec and Probiodrug enter development collaboration for novel enzyme target

Nov. 30, 2012

MorphoSys and Lanthio Pharma agree to develop new class of therapeutic peptides

Nov. 27, 2012

RNAi modifications: Progression from the bench to the clinic

Nov. 21, 2012

Integral Molecular and Crystal Bioscience enter research collaboration

Nov. 19, 2012

Fujifilm provides update on development of micro-needle array delivery technology

Nov. 16, 2012

Inovio Pharmaceuticals expands synthetic vaccine license with University of Pennsylvania

Nov. 16, 2012

MorphoSys and Novartis expand antibody alliance

Nov. 8, 2012

RaQualia Pharma and Ajinomoto Pharmaceuticals establish collaboration

Nov. 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2025.
NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 5, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...